Quadrant Capital Group LLC Invitae Corp Transaction History

Quadrant Capital Group LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$1.2 - $2.73 $277 - $630	-231 Reduced 47.83%	252 $0
Q4 2022 Feb 10, 2023	BUY	$1.71 - $3.61 $403 - $851	236 Added 95.55%	483 $0
Q3 2022 Nov 10, 2022	BUY	$1.9 - $8.63 $469 - $2,131	247 New	247 $1,000
Q2 2022 Aug 09, 2022	SELL	$2.13 - $9.01 $1,299 - $5,496	-610 Closed	0 $0
Q1 2022 May 06, 2022	BUY	$6.28 - $15.59 $3,190 - $7,919	508 Added 498.04%	610 $5,000
Q4 2021 Feb 01, 2022	BUY	$14.7 - $28.67 $1,367 - $2,666	93 Added 1033.33%	102 $2,000
Q3 2021 Nov 12, 2021	SELL	$24.31 - $33.6 $6,879 - $9,508	-283 Reduced 96.92%	9 $0
Q2 2021 Aug 09, 2021	BUY	$26.09 - $40.4 $6,679 - $10,342	256 Added 711.11%	292 $10,000
Q4 2020 Feb 16, 2021	BUY	$39.09 - $57.4 $234 - $344	6 Added 20.0%	36 $2,000
Q3 2020 Nov 13, 2020	BUY	$28.43 - $44.67 $852 - $1,340	30 New	30 $1,000

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

Stay updated on Quadrant Capital Group LLC with notifications on news.